首站-论文投稿智能助手
典型文献
Screening of novel synthetic derivatives of dehydroepiandrosterone for antivirals against flaviviruses infections
文献摘要:
Flaviviruses are important arthropod-borne pathogens that represent an immense global health problem.Their unprecedented epidemic rate and unpredictable clinical features underscore an urgent need for antiviral in-terventions.Dehydroepiandrosterone(DHEA)is a natural occurring adrenal-derived steroid in the human body that has been associated in protection against various infections.In the present study,the plaque assay based primary screening was conducted on 32 synthetic derivatives of DHEA against Japanese encephalitis virus(JEV)to identify potent anti-flaviviral compounds.Based on primary screening,HAAS-AV3026 and HAAS-AV3027 were selected as hits from DHEA derivatives that exhibited strong antiviral activity against JEV(IC50=2.13 and 1.98 umol/L,respectively)and Zika virus(ZIKV)(IC50=3.73 and 3.42 umol/L,respectively).Mechanism study in-dicates that HAAS-AV3026 and HAAS-AV3027 do not exhibit inhibitory effect on flavivirus binding and entry process,while significantly inhibit flavivirus infection at the replication stage.Moreover,indirect immunofluo-rescence assay,Western blot analyses,and quantitative reverse transcription-PCR(qRT-PCR)revealed a potent antiviral activity of DHEA derivatives hits against JEV and ZIKV in terms of inhibition of viral infection,protein production,and viral RNA synthesis in Vero cells.Taken together,our results may provide a basis for the development of new antivirals against flaviviruses.
文献关键词:
作者姓名:
Muhammad Imran;Luping Zhang;Bohan Zheng;Zikai Zhao;Dengyuan Zhou;Shengfeng Wan;Zheng Chen;Hongyu Duan;Qiuyan Li;Xueqin Liu;Shengbo Cao;Shaoyong Ke;Jing Ye
作者机构:
State Key Laboratory of Agricultural Microbiology,Huazhong Agricultural University,Wuhan,430070,China;Key Laboratory of Preventive Veterinary Medicine in Hubei Province,College of Veterinary Medicine,Huazhong Agricultural University,Wuhan,430070,China;The Cooperative Innovation Center for Sustainable Pig Production,Huazhong Agricultural University,Wuhan,430070,China;Department of Pathology,Faculty of Veterinary Science,University of Agriculture,Faisalabad,38040,Pakistan;Department of Nephrology,Henan Provincial Key Laboratory of Kidney Diseases and Immunology,Henan Provincial People's Hospital,Zhengzhou,450003,China;Key Laboratory for Animal Health of Jiangxi Province,Nanchang 330045,China;Department of Preventive Veterinary Medicine,College of Animal Science and Technology,Jiangxi Agricultural University,Nanchang 330045,China;College of Fisheries,Huazhong Agricultural University,Wuhan,430070,China;National Biopesticide Engineering Research Center,Hubei Biopesticide Engineering Research Center,Hubei Academy of Agricultural Sciences,Wuhan,430070,China
文献出处:
引用格式:
[1]Muhammad Imran;Luping Zhang;Bohan Zheng;Zikai Zhao;Dengyuan Zhou;Shengfeng Wan;Zheng Chen;Hongyu Duan;Qiuyan Li;Xueqin Liu;Shengbo Cao;Shaoyong Ke;Jing Ye-.Screening of novel synthetic derivatives of dehydroepiandrosterone for antivirals against flaviviruses infections)[J].中国病毒学,2022(01):94-106
A类:
Flaviviruses,terventions,flaviviral,AV3026,AV3027,immunofluo
B类:
Screening,novel,synthetic,derivatives,dehydroepiandrosterone,antivirals,against,flaviviruses,infections,are,important,arthropod,borne,pathogens,that,represent,immense,global,health,problem,Their,unprecedented,epidemic,rate,unpredictable,clinical,features,underscore,urgent,need,Dehydroepiandrosterone,DHEA,natural,occurring,adrenal,derived,steroid,human,body,has,been,associated,protection,various,In,study,plaque,assay,primary,screening,was,conducted,Japanese,encephalitis,JEV,identify,potent,compounds,Based,HAAS,were,selected,hits,from,exhibited,strong,activity,IC50,umol,respectively,Zika,ZIKV,Mechanism,dicates,do,not,inhibitory,effect,binding,entry,process,while,significantly,replication,stage,Moreover,indirect,rescence,blot,analyses,quantitative,reverse,transcription,qRT,revealed,terms,inhibition,protein,production,synthesis,Vero,cells,Taken,together,our,results,may,provide,basis,development,new
AB值:
0.545267
相似文献
Deubiquitinase ubiquitin-specific protease 3 (USP3) inhibits HIV-1 replication via promoting APOBEC3G (A3G) expression in both enzyme activity-dependent and -independent manners
Zhao Simin;Zheng Baisong;Wang Liuli;Cui Wenzhe;Jiang Chunlai;Li Zhuo;Gao Wenying;Zhang Wenyan-Center for Pathogen Biology and Infectious Diseases, Institute of Virology and AIDS Research, Key Laboratory of Organ Regeneration and Transplantation of The Ministry of Education, The First Hospital of Jilin University, Changchun, Jilin 130021, China;College of Life Science of Jilin University, Changchun, Jilin 130012, China;Department of Regenerative Medicine, School of Pharmaceutical Sciences, Jilin University, Changchun, Jilin 130012, China;Jilin Provincial Key Laboratory on Molecular and Chemical Genetics, The Second Hospital of Jilin University, Changchun, Jilin 130041, China;Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, Jilin 130021, China
Comparison of viral RNA-host protein interactomes across pathogenic RNA viruses informs rapid antiviral drug discovery for SARS-CoV-2
Shaojun Zhang;Wenze Huang;Lili Ren;Xiaohui Ju;Mingli Gong;Jian Rao;Lei Sun;Pan Li;Qiang Ding;Jianwei Wang;Qiangfeng Cliff Zhang-MOE Key Laboratory of Bioinformatics,Beijing Advanced Innovation Center for Structural Biology & Frontier Research Center for Biological Structure,Center for Synthetic and Systems Biology,Tsinghua-Peking Joint Center for Life Sciences,School of Life Sciences,Tsinghua University,Beijing,China;NHC Key Laboratory of Systems Biology of Pathogens and Christophe Mérieux Laboratory,Institute of Pathogen Biology,Chinese Academy of Medical Sciences & Peking Union Medical College,Beijing,China;Key Laboratory of Respiratory Disease Pathogenomics,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,China;Center for infectious Disease Research,School of Medicine,Tsinghua University,Beijing,China
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
Discovery of novel antagonists targeting the DNA binding domain of androgen receptor by integrated docking-based virtual screening and bioassays
Jin-ping Pang;Chao Shen;Wen-fang Zhou;Yun-xia Wang;Lu-hu Shan;Xin Chai;Ying Shao;Xue-ping Hu;Feng Zhu;Dan-yan Zhu;Li Xiao;Lei Xu;Xiao-hong Xu;Dan Li;Ting-jun Hou-Hangzhou Institute of Innovative Medicine,College of Pharmaceutical Sciences,Zhejiang University,Hangzhou 310058,China;Institute of Cancer Research and Basic Medical Sciences of Chinese Academy of Sciences,Cancer Hospital of University of Chinese Academy of Sciences,Zhejiang Cancer Hospital,Hangzhou 310022,China;School of Life Science,Huzhou University,Huzhou 313000,China;Institute of Bioinformatics and Medical Engineering,School of Electrical and Information Engineering,Jiangsu University of Technology,Changzhou 213001,China;State Key Lab of CAD&CG,Zhejiang University,Hangzhou 310058,China
Discovery of SARS-CoV-2-E channel inhibitors as antiviral candidates
Yi Wang;Sui Fang;Yan Wu;Xi Cheng;Lei-ke Zhang;Xu-rui Shen;Shuang-qu Li;Jian-rong Xu;Wei-juan Shang;Zhao-bing Gao;Bing-qing Xia-CAS Key Laboratory of Receptor Research,Stake Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;University of Chinese Academy of Sciences,Beijing 100049,China;State Key Laboratory of Virology,Wuhan Institute of Virology,Center for Biosafety Mega-Science,Chinese Academy of Sciences,Wuhan 430071,China;Academy of Integrative Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;Department of Pharmacology and Chemical Biology,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China;Zhongshan Institute of Drug Discovery,Institution for Drug Discovery Innovation,Chinese Academy of Science,Zhongshan 528400,China
The novel indomethacin derivative CZ-212-3 exerts antitumor effects on castration-resistant prostate cancer by degrading androgen receptor and its variants
Hong Wang;Zhe Chang;Guo-di Cai;Ping Yang;Jiang-he Chen;Shan-shu Yang;Yin-feng Guo;Ming-yu Wang;Xue-hua Zheng;Jin-ping Lei;Pei-qing Liu;De-peng Zhao;Jun-jian Wang-School of Pharmaceutical Sciences,Sun Yat-sen University,Guangzhou 510006,China;State Key Laboratory of Oncology in South China,Collaborative Innovation Center for Cancer Medicine,Guangzhou 510060,China;Department of Pathology,Sun Yat-sen University Cancer Center,Guangzhou 510060,China;Key Laboratory of Molecular Target and Clinical Pharmacology,School of Pharmaceutical Sciences and the Fifth Affiliated Hospital,Guangzhou Medical University,Guangzhou 510006,China;Guangdong Provincial Key Laboratory of New Drug Design and Evaluation,School of Pharmaceutical Sciences,Sun Yat-sen University,Guangzhou 510006,China;National-Local Joint Engineering Laboratory of Druggability and New Drugs Evaluation,Sun Yat-sen University,Guangzhou 510006,China
Discovery of a novel DDRs kinase inhibitor XBLJ-13 for the treatment of idiopathic pulmonary fibrosis
Ying Dong;Bi-xi Tang;Qi Wang;Li-wei Zhou;Cong Li;Xuan Zhang;Dan-dan Sun;Xin Sun;Xue-mei Zhang;Bing Xiong;Jia Li;Hong Shi;Dan-qi Chen;Yi Zang-State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;University of Chinese Academy of Sciences,Beijing 100049,China;Department of Pharmacology,School of Pharmacy,Fudan University,Shanghai 201203,China;Department of Medicinal Chemistry,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;Center for Supramolecular Chemistry and Catalysis and Department of Chemistry,College of Sciences,Shanghai University,Shanghai 200444,China;Schoolof Chinese Materia Medica,Nanjing University of Chinese Medicine,Nanjing 210023,China;Schoolof Pharmacy,Henan University,Kaifeng 475004,China;Open Studio for Druggability Research of Marine Natural Products,Pilot National Laboratory for Marine Science and Technology(Qingdao),Qingdao 266237,China;School of Pharmaceutical Science and Technology,Hangzhou Institute for Advanced Study,UCAS,Hangzhou 310024,China;Department of Anesthesiology of Shanghai Pulmonary Hospital,School of medicine,Tongji University,Shanghai 200433,China
Design,synthesis and pharmacological characterization of N-(3-ethylbenzo[d]isoxazol-5-yl)sulfonamide derivatives as BRD4 inhibitors against acute myeloid leukemia
Mao-feng Zhang;Xiao-yu Luo;Cheng Zhang;Chao Wang;Xi-shan Wu;Qiu-ping Xiang;Yong Xu;Yan Zhang-College of Pharmacy,Taizhou Polytechnic College,Taizhou 225300,China;Guangzhou Younan Technology Co.,Ltd,Guangzhou 510663,China;Center for Chemical Biology and Drug Discovery,Guangzhou Institutes of Biomedicine and Health,Chinese Academy of Sciences,Guangzhou 510530,China;University of Chinese Academy of Sciences,Beijing 100049,China;State Key Laboratory of Respiratory Disease,Guangzhou Institutes of Biomedicine and Health,Chinese Academy of Sciences,Guangzhou 510530,China;China-New Zealand Joint Laboratory on Biomedicine and Health,Guangzhou 510530,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。